Corporate GovernanceJul 2, 2026, 06:22 AM
Vaxart Resolves Proxy Contest, Enhances Corporate Governance
AI Summary
Vaxart, Inc. has entered into a Cooperation Agreement with a Stockholder Group, resolving a proxy contest ahead of the 2026 Annual Meeting. Under the agreement, the Stockholder Group withdrew its director nominations and demand to inspect company records. Vaxart will work with the group to appoint a new independent director to its Board, who will also serve on the Nominating and Corporate Governance Committee. Additionally, the company will implement new corporate governance enhancements, including a director resignation policy, stock ownership guidelines, and the formation of new Board committees.
Key Highlights
- Vaxart entered a Cooperation Agreement with a Stockholder Group on July 1, 2026.
- Stockholder Group withdrew its notice nominating three director candidates for the 2026 Annual Meeting.
- Company and Stockholder Group will identify and appoint a new independent director to the Board.
- New director will be appointed to the Nominating and Corporate Governance Committee.
- Board will adopt a resignation policy for incumbent directors in uncontested elections.
- Board will adopt stock ownership guidelines for directors.
- Board will form a Clinical and Regulatory Affairs Committee and a Stockholder Engagement Committee.
- Vaxart agreed to reimburse the Stockholder Group up to $650,000 for engagement and solicitation efforts.
Price Impact
More from VXRT